Kuhn TS: The structure of scientific revolutions. 2nd edition. University of Chicago Press; Chicago, IL: 1970

Toward precision medicine: Building a knowledge network for biomedical research and a new taxonomy of disease. National Academies Press (US); Washington, DC: 2011

Hellenic Network of Precision Medicine on Cancer: What does precision medicine mean? https://oncopmnet.gr/?page_id=2784&lang=en. Accessed July 15, 2021.

Kohler S: Precision medicine-moving away from one-size-fits-all. Quest Science for South Africa. 14. Academy of Science of South Africa; Pretoria: pp. 12–15. 2018

Garraway LA and Lander ES: Lessons from the cancer genome. Cell. 153:17–37. 2013. View Article : Google Scholar

Re A, Nardella C, Quattrone A and Lunardi A: Editorial: Precision medicine in oncology. Front Oncol. 8:4792018. View Article : Google Scholar : PubMed/NCBI

Garraway LA, Verweij J and Ballman KV: Precision oncology: An overview. J Clin Oncol. 31:1803–1805. 2013. View Article : Google Scholar : PubMed/NCBI

Garraway LA: Genomics-driven oncology: Framework for an emerging paradigm. J Clin Oncol. 31:1806–1814. 2013. View Article : Google Scholar : PubMed/NCBI

Hyman DM, Taylor BS and Baselga J: Implementing genome-driven oncology. Cell. 168:584–599. 2017. View Article : Google Scholar :

Sakurai M and Sandberg AA: Chromosomes and causation of human cancer and leukemia. XI. Correlation of karyotypes with clinical features of acute myeloblastic leukemia. Cancer. 37:285–299. 1976. View Article : Google Scholar : PubMed/NCBI

Flores M, Glusman G, Brogaard K, Price ND and Hood L: P4 medicine: How systems medicine will transform the healthcare sector and society. Per Med. 10:565–576. 2013. View Article : Google Scholar

Hood L, Balling R and Auffray C: Revolutionizing medicine in the 21st century through systems approaches. Biotechnol J. 7:992–1001. 2012. View Article : Google Scholar : PubMed/NCBI

Hood L, Heath JR, Phelps ME and Lin B: Systems biology and new technologies enable predictive and preventative medicine. Science. 306:640–643. 2004. View Article : Google Scholar : PubMed/NCBI

Weston AD and Hood L: Systems biology, proteomics, and the future of health care: Toward predictive, preventative, and personalized medicine. J Proteome Res. 3:179–196. 2004. View Article : Google Scholar : PubMed/NCBI

International Human Genome and Sequencing Consortium: Finishing the euchromatic sequence of the human genome. Nature. 431:931–945. 2004. View Article : Google Scholar

Harmston N, Filsell W and Stumpf MP: What the papers say: Text mining for genomics and systems biology. Hum Genomics. 5:17–29. 2010. View Article : Google Scholar

Dong L, Wang W, Li A, Kansal R, Chen Y, Chen H and Li X: Clinical next generation sequencing for precision medicine in cancer. Curr Genomics. 16:253–263. 2015. View Article : Google Scholar

Behjati S and Tarpey PS: What is next generation sequencing? Arch Dis Child Educ Pract Ed. 98:236–238. 2013. View Article : Google Scholar : PubMed/NCBI

International Cancer Genome Consortium; Hudson TJ, Anderson W, Artez A, Barker AD, Bell C, Bernabé RR, Bhan MK, Calvo F, Eerola I, et al International network of cancer genome projects. Nature. 464:993–998. 2010. View Article : Google Scholar : PubMed/NCBI

De Souza YG and Greenspan JS: Biobanking past, present and future: Responsibilities and benefits. AIDS. 27:303–312. 2013. View Article : Google Scholar

Loft S and Poulsen HE: Cancer risk and oxidative DNA damage in man. J Mol Med (Berl). 74:297–312. 1996. View Article : Google Scholar

Castillo-Pelayo T, Babinszky S, LeBlanc J and Watson PH: The importance of biobanking in cancer research. Biopreserv Biobank. 13:172–177. 2015. View Article : Google Scholar : PubMed/NCBI

Kinkorová J: Biobanks in the era of personalized medicine: Objectives, challenges, and innovation: Overview. EPMA J. 7:42016. View Article : Google Scholar : PubMed/NCBI

Patil S, Majumdar B, Awan KH, Sarode GS, Sarode SC, Gadbail AR and Gondivkar S: Cancer oriented biobanks: A comprehensive review. Oncol Rev. 12:3572018.PubMed/NCBI

Coppola L, Cianflone A, Grimaldi AM, Incoronato M, Bevilacqua P, Messina F, Baselice S, Soricelli A, Mirabelli P and Salvatore M: Biobanking in health care: Evolution and future directions. J Transl Med. 17:1722019. View Article : Google Scholar : PubMed/NCBI

Watson PH and Barnes RO: A proposed schema for classifying human research biobanks. Biopreserv Biobank. 9:327–333. 2011. View Article : Google Scholar

European Commission: Biobanks for Europe: A Challenge for Governance. Directorate-General for Research and Innovation Science in society, EUR 25302 EN; 2012

Harris JR, Burton P, Knoppers BM, Lindpaintner K, Bledsoe M, Brookes AJ, Budin-Ljøsne I, Chisholm R, Cox D, Deschênes M, et al: Toward a roadmap in global biobanking for health. Eur J Hum Genet. 20:1105–1111. 2012. View Article : Google Scholar : PubMed/NCBI

Yuille M, van Ommen GJ, Bréchot C, Cambon-Thomsen A, Dagher G, Landegren U, Litton JE, Pasterk M, Peltonen L, Taussig M, et al: Biobanking for Europe. Brief Bioinform. 9:14–24. 2008. View Article : Google Scholar

Catchpoole DR, Florindi F, Ahern C, Garcia DL, Mullins P, Van Enckevort E, Zaayenga A, Mayrhofer MT and Holub P: Expanding the BBMRI-ERIC directory into a global catalogue of COVID-19-ready collections: A joint initiative of BBMRI-ERIC and ISBER. Biopreserv Biobank. 18:479–480. 2020. View Article : Google Scholar

Brand AM and Probst-Hensch NM: Biobanking for epidemiological research and public health. Pathobiology. 74:227–238. 2007. View Article : Google Scholar : PubMed/NCBI

Riegman PH, Dinjens WN and Oosterhuis JW: Biobanking for interdisciplinary clinical research. Pathobiology. 74:239–244. 2007. View Article : Google Scholar : PubMed/NCBI

Mendy M, Caboux E, Lawlor RT, Wright J and Wild CP: Common minimum technical standards and protocols for biobanks dedicated to cancer research. (IARC Technical Publication No. 44). International Agency for Research on Cancer; Lyon: 2017

Slokenberga S, Tzortzatou O and Reichel J: GDPR and biobanking: Individual rights, public interest and research regulation across Europe. Springer International Publishing; Cham: pp. 291–307. 2021

Lee LW, Griffith J, Zenick H and Hulka BS: Human tissue monitoring and specimen banking: Opportunities for exposure assessment, risk assessment, and epidemiologic research. Environ Health Perspect. 103(Suppl 3): S3–S8. 1995.

Palazzani L: Innovation in Scientific Research and Emerging Technologies: A Challenge to Ethics and Law. Springer Nature; 2019, View Article : Google Scholar

Pitt KE, Campbell L, Skubitz APN, Aamodt RL, Anouna A, Baird P, Beck JC, Bledsoe M, De Souza Y, Grizzle W, et al: Best practices for repositories I: Collection, storage, and retrieval of human biological materials for research. Cell Preserv Technol. 3:5–48. 2005. View Article : Google Scholar

ISBER: Best practices for repositories: Collection storage, retrieval and distribution of biological materials for research. Cell Preserv Technol. 6:3–58. 2008. View Article : Google Scholar

Campbell LD, Betsou F, Garcia DL, Giri JG, Pitt KE, Pugh RS, Sexton KC, Skubitz AP and Somiari SB: Development of the ISBER best practices for repositories: Collection, storage, retrieval and distribution of biological materials for research. Biopreserv Biobank. 10:232–233. 2012. View Article : Google Scholar

Campbell LD, Astrin JJ, DeSouza Y, Giri J, Patel AA, Rawley-Payne M, Rush A and Sieffert N: The 2018 revision of the ISBER best practices: Summary of changes and the editorial team's development process. Biopreserv Biobank. 16:3–6. 2018. View Article : Google Scholar

Brochhausen M, Fransson MN, Kanaskar NV, Eriksson M, Merino-Martinez R, Hall RA, Norlin L, Kjellqvist S, Hortlund M, Topaloglu U, et al: Developing a semantically rich ontology for the biobank-administration domain. J Biomed Semantics. 4:232013. View Article : Google Scholar

Eklund N, Andrianarisoa NH, van Enckevort E, Anton G, Debucquoy A, Müller H, Zaharenko L, Engels C, Ebert L, Neumann M, et al: Extending the minimum information about biobank data sharing terminology to describe samples, sample donors, and events. Biopreserv Biobank. 18:155–164. 2020. View Article : Google Scholar

Merino-Martinez R, Norlin L, van Enckevort D, Anton G, Schuffenhauer S, Silander K, Mook L, Holub P, Bild R, Swertz M and Litton JE: Toward global biobank integration by implementation of the minimum information about biobank data sharing (MIABIS 2.0 Core). Biopreserv Biobank. 14:298–306. 2016. View Article : Google Scholar : PubMed/NCBI

Norlin L, Fransson MN, Eriksson M, Merino-Martinez R, Anderberg M, Kurtovic S and Litton JE: A minimum data set for sharing biobank samples, information, and data: MIABIS. Biopreserv Biobank. 10:343–348. 2012. View Article : Google Scholar : PubMed/NCBI

National Cancer Institute (NCI): NCI Best Practices for Biospecimen Resources. NCI; Bethesda, MD: 2021, https://biospecimens.cancer.gov/. Accessed January 13, 2021.

Betsou F, Lehmann S, Ashton G, Barnes M, Benson EE, Coppola D, DeSouza Y, Eliason J, Glazer B, Guadagni F, et al: Standard preanalytical coding for biospecimens: Defining the sample PREanalytical code. Cancer Epidemiol Biomarkers Prev. 19:1004–1011. 2010. View Article : Google Scholar

Sándor J, Drakopoulou A and Bárd P: The legal regulation of biobanks: National report: Greece. (CELEB Paper Series, No 2). 2009. View Article : Google Scholar

Papadavid E, Korkolopoulou P, Levidou G, Saetta AA, Papadaki T, Siakantaris M, Nikolaou V, Oikonomidi A, Chatziandreou I, Marinos L, et al: In situ assessment of PI3K and PTEN alterations in mycosis fungoides: Correlation with clinicopathological features. 23:931–933. 2014.PubMed/NCBI

Argyropoulos KV, Pulitzer M, Perez S, Korkolopoulou P, Angelopoulou M, Baxevanis C, Palomba ML and Siakantaris M: Tumor-infiltrating and circulating granulocytic myeloid-derived suppressor cells correlate with disease activity and adverse clinical outcomes in mycosis fungoides. Clin Transl Oncol. 22:1059–1066. 2020. View Article : Google Scholar

Mansouri L, Noerenberg D, Young E, Mylonas E, Abdulla M, Frick M, Asmar F, Ljungström V, Schneider M, Yoshida K, et al: Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma. Blood. 128:2666–2670. 2016. View Article : Google Scholar : PubMed/NCBI

Lakiotaki E, Levidou G, Angelopoulou MK, Adamopoulos C, Pangalis G, Rassidakis G, Vassilakopoulos T, Gainaru G, Flevari P, Sachanas S, et al: Potential role of AKT/mTOR signalling proteins in hairy cell leukaemia: Association with BRAF/ERK activation and clinical outcome. Sci Rep. 6:212522016. View Article : Google Scholar : PubMed/NCBI

Sachanas S, Pangalis GA, Vassilakopoulos TP, Korkolopoulou P, Kontopidou FN, Athanasoulia M, Yiakoumis X, Kalpadakis C, Georgiou G, Masouridis S, et al: Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: A highly effective regimen. Leuk Lymphoma. 52:387–393. 2011. View Article : Google Scholar

Pouliou E, Xochelli A, Kanellis G, Stalika E, Sutton LA, Nava r ro A, Agathangelidis A, Dimosthenous K, Anagnostopoulos A, Patsouris E, et al: Numerous ontogenetic roads to mantle cell lymphoma: Immunogenetic and immunohistochemical evidence. Am J Pathol. 187:1454–1458. 2017. View Article : Google Scholar : PubMed/NCBI

Vassilakopoulos P: Levidou T, Milionis G, Hartmann V, Lakiotaki S, Sepsa E, Thymara A, Ntailiani I, Spanou P, Angelopoulou K K M, et al Thioredoxin-1, chemokine (C-X-C motif) ligand-9 and interferon-γ expression in the neoplastic cells and macrophages of Hodgkin lymphoma: Clinicopathologic correlations and potential prognostic implications. Leuk Lymphoma. 58:1–13. 2017. View Article : Google Scholar

Dimtsas GS, Georgiadi EC, Karakitsos P, Vassilakopoulos TP, Thymara I, Korkolopoulou P, Patsouris E, Kittas C and Doussis-Anagnostopoulou IA: Prognostic significance of immunohistochemical expression of the angiogenic molecules vascular endothelial growth factor-A, vascular endothelial growth factor receptor-1 and vascular endothelial growth factor receptor-2 in patients with classical Hodgkin lymphoma. Leuk Lymphoma. 55:558–564. 2014. View Article : Google Scholar

Lakiotaki E, Giaginis C, Tolia M, Alexandrou P, Delladetsima I, Giannopoulou I, Kyrgias G, Patsouris E and Theocharis S: Clinical significance of cannabinoid receptors CB1 and CB2 expression in human malignant and benign thyroid lesions. Biomed Res Int. 2015:8394032015. View Article : Google Scholar

Dimonitsas E, Liakea A, Sakellariou S, Thymara I, Giannopoulos A, Stratigos A, Soura E, Saetta A and Korkolopoulou P: An update on molecular alterations in melanocytic tumors with emphasis on Spitzoid lesions. Ann Transl Med. 6:2492018. View Article : Google Scholar : PubMed/NCBI

Kostaki M, Manona AD, Stavraka I, Korkolopoulou P, Levidou G, Trigka EA, Christofidou E, Champsas G, Stratigos AJ, Katsambas A, et al: High-frequency p16(INK) (4A) promoter methylation is associated with histone methyltransferase SETDB1 expression in sporadic cutaneous melanoma. Exp Dermatol. 23:332–338. 2014. View Article : Google Scholar

Davies NP, Wilson M, Harris LM, Natarajan K, Lateef S, Macpherson L, Sgouros S, Grundy RG, Arvanitis TN and Peet AC: Identification and characterisation of childhood cerebellar tumours by in vivo proton MRS. NMR Biomed. 21:908–918. 2008. View Article : Google Scholar

Levidou G, Siakantaris M, Papadaki T, Papadavid E, Vassilakopoulos TP, Angelopoulou MK, Marinos L, Nikolaou V, Economidi A, Antoniou C, et al: A comprehensive immunohistochemical approach of AKT/mTOR pathway and p-STAT3 in mycosis fungoides. J Am Acad Dermatol. 69:375–384. 2013. View Article : Google Scholar

Rassidakis GZ, Medeiros LJ, Vassilakopoulos TP, Viviani S, Bonfante V, Nadali G, Herling M, Angelopoulou MK, Giardini R, Chilosi M, et al: BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens. Blood. 100:3935–3941. 2002. View Article : Google Scholar

Georgiadi EC, Sachinis N, Dimtsas G, Vassilakopoulos TP, Kittas C and Doussis-Anagnostopoulou IA: Evaluation of apoptosis in classical Hodgkin's lymphoma comparing different methods. J BUON. 17:746–752. 2012.

Lippi G, Simundic AM, Rodriguez-Manas L, Bossuyt P and Banfi G: Standardizing in vitro diagnostics tasks in clinical trials: A call for action. Ann Transl Med. 4:1812016. View Article : Google Scholar : PubMed/NCBI

Mendy M, Caboux E, Lawlor RT, Wright J and Wild CP: Common minimum technical standards and protocols for biobanks dedicated to cancer research. World Health Organization, International Agency for Research on Cancer; Lyon: 2017

Betsou F: Quality assurance and quality control in biobanking. Biobanking of Human Biospecimens: Principles and Practice. Hainaut P, Vaught J, Zatloukal K and Pasterk M: Springer International Publishing; Cham: pp. 23–49. 2017, View Article : Google Scholar

Betsou F, Bulla A, Cho SY, Clements J, Chuaqui R, Coppola D, De Souza Y, De Wilde A, Grizzle W, Guadagni F, et al: Assays for qualification and quality stratification of clinical biospecimens used in research: A technical report from the isber biospecimen science working group. Biopreserv Biobank. 14:398–409. 2016. View Article : Google Scholar : PubMed/NCBI

Spencer DH, Sehn JK, Abel HJ, Watson MA, Pfeifer JD and Duncavage EJ: Comparison of clinical targeted next-generation sequence data from formalin-fixed and fresh-frozen tissue specimens. J Mol Diagn. 15:623–633. 2013. View Article : Google Scholar : PubMed/NCBI

Graw S, Meier R, Minn K, Bloomer C, Godwin AK, Fridley B, Vlad A, Beyerlein P and Chien J: Robust gene expression and mutation analyses of RNA-sequencing of formalin-fixed diagnostic tumor samples. Sci Rep. 5:123352015. View Article : Google Scholar

Norton N, Sun Z, Asmann YW, Serie DJ, Necela BM, Bhagwate A, Jen J, Eckloff BW, Kalari KR, Thompson KJ, et al: Gene expression, single nucleotide variant and fusion transcript discovery in archival material from breast tumors. PLoS One. 8:e819252013. View Article : Google Scholar : PubMed/NCBI

Kokkat TJ, Patel MS, McGarvey D, LiVolsi VA and Baloch ZW: Archived formalin-fixed paraffin-embedded (FFPE) blocks: A valuable underexploited resource for extraction of DNA, RNA, and protein. Biopreserv Biobank. 11:101–106. 2013. View Article : Google Scholar

Hedegaard J, Thorsen K, Lund MK, Hein AM, Hamilton-Dutoit SJ, Vang S, Nordentoft I, Birkenkamp-Demtröder K, Kruhøffer M, Hager H, et al: Next-generation sequencing of RNA and DNA isolated from paired fresh-frozen and formalin-fixed paraffin-embedded samples of human cancer and normal tissue. PLoS One. 9:e981872014. View Article : Google Scholar

Kerick M, Isau M, Timmermann B, Sültmann H, Herwig R, Krobitsch S, Schaefer G, Verdorfer I, Bartsch G, Klocker H, et al: Targeted high throughput sequencing in clinical cancer settings: Formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity. BMC Med Genomics. 4:682011. View Article : Google Scholar : PubMed/NCBI

GitHub: MIABIS: Minimum information about biobank data sharing repository. https://github.com/BBMRI-ERIC/miabis. Accessed January 20, 2021.

BBMRI-ERIC: Common Services IT: What are we aiming to achieve? BBMRI-ERIC, Graz. 2021, https://www.bbmri-eric.eu/bbmri-eric/common-service-it/. Accessed February 29, 2021.

Yesley MS: What's ELSI got to do with it? Bioethics and the human genome project. New Genet Soc. 27:1–6. 2008. View Article : Google Scholar

Council of Europe: Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: Convention on Human Rights and Biomedicine (ETS No. 164). https://www.coe.int/en/web/conven-tions/full-list?module=treaty-detail&treatynum=164. Accessed January 17, 2021.

European Commission: Clinical trials - Regulation EU 536/2014. https://ec.europa.eu/health/human-use/clinical-trials/regulation_en. Accessed January 17, 2021.

Council of Europe: Convention for the Protection of Human Rights and Fundamental Freedoms (ETS No. 005). https://www.coe.int/en/web/conventions/full-list/-/conventions/treaty/005. Accessed January 16, 2021.

Council of Europe: Convention for the Protection of Individuals with regard to Automatic Processing of Personal Data (ETS No. 108). https://www.coe.int/en/web/conventions/full-list/-/conventions/treaty/108. Accessed January 16, 2021.

Council of Europe: Convention for the protection of human rights and dignity of the Human Being with regard to the application of biology and medicine: Convention on Human Rights and Biomedicine (ETS No. 164). https://www.coe.int/en/web/conventions/full-list/-/conventions/treaty/164. Accessed January 15, 2021.

Council of Europe: Data Protection Directive. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A31995L0046. Accessed January 16, 2021.

Council of Europe: Recommendation CM/Rec (2016) 6 of the Committee of Ministers to member States on research on biological materials of human origin. https://search.coe.int/cm/Pages/result_details.aspx?ObjectID=090000168064e8ff#globalcontainer. Accessed January 15, 2021.

United Nations: Universal declaration of human rights. https://www.un.org/en/universal-declaration-human-rights/. Accessed January 15, 2021.

Council of Europe: Setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A32004L0023. Accessed January 16, 2021.

World Medical Association: The declaration of Helsinki - Ethical principles for medical research involving human subjects (Last amended 2013). https://www.wma.net/policies-post/wma-decla-ration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/. Accessed June 13, 2021.

World Medical Association: The declaration of Taipei on Ethical considerations regarding health databases and biobanks (Last revised 2016). https://www.wma.net/policies-post/wma-declaration-of-taipei-on-ethical-consid-erations-regarding-health-databases-and-biobanks/. Accessed June 13, 2021.

National Bioethics Commission: On banks of biological material of human origin (biobanks) in biomedical research. http://www.bioethics.gr/images/pdf/ENGLISH/OPINIONS_REPORTS/biobanks_recom_eng.pdf. Accessed December 27, 2020.

Daemen J and Rijmen V: The block cipher rijndael. Lecture Notes in Computer Science. 1820. Springer-Verlag; Berlin: pp. 277–284. 2000, View Article : Google Scholar

Nechvatal J, Barker E, Bassham L, Burr W, Dworkin M, Foti J and Roback E: Report on the development of the advanced encryption standard (AES). J Res Natl Inst Stand Technol. 106:511–577. 2001. View Article : Google Scholar

Wendler D: Broad versus blanket consent for research with human biological samples. Hastings Cent Rep. 43:3–4. 2013. View Article : Google Scholar

Grady C, Eckstein L, Berkman B, Brock D, Cook-Deegan R, Fullerton SM, Greely H, Hansson MG, Hull S, Kim S, et al: Broad consent for research with biological samples: Workshop conclusions. Am J Bioeth. 15:34–42. 2015. View Article : Google Scholar

Gille F, Vayena E and Blasimme A: Future-proofing biobanks' governance. Eur J Hum Genet. 28:989–996. 2020. View Article : Google Scholar : PubMed/NCBI

Juliusson G and Hough R: Leukemia. Prog Tumor Res. 43:87–100. 2016. View Article : Google Scholar

Haferlach T and Schmidts I: The power and potential of integrated diagnostics in acute myeloid leukaemia. Br J Haematol. 188:36–48. 2020. View Article : Google Scholar :

Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, et al: WHO-EORTC classification for cutaneous lymphomas. Blood. 105:3768–3785. 2005. View Article : Google Scholar : PubMed/NCBI

Kempf W, Zimmermann AK and Mitteldorf C: Cutaneous lymphomas-an update 2019. Hematol Oncol. 37(Suppl 1): S43–S47. 2019. View Article : Google Scholar

Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH and Jaffe ES: The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 133:1703–1714. 2019. View Article : Google Scholar :

Hernández JM, del Cañizo MC, Cuneo A, García JL, Gutiérrez NC, González M, Castoldi G and San Miguel JF: Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia. Ann Oncol. 11:441–444. 2000. View Article : Google Scholar : PubMed/NCBI

Hernández L, Beà S, Pinyol M, Ott G, Katzenberger T, Rosenwald A, Bosch F, López-Guillermo A, Delabie J, Colomer D, et al: CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus. Cancer Res. 65:2199–2206. 2005. View Article : Google Scholar

Li S, Young KH and Medeiros LJ: Diffuse large B-cell lymphoma. Pathology. 50:74–87. 2018. View Article : Google Scholar

Horsman DE, Gascoyne RD, Coupland RW, Coldman AJ and Adomat SA: Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14; 18) in follicular lymphoma. Am J Clin Pathol. 103:472–478. 1995. View Article : Google Scholar : PubMed/NCBI

Rowley JD: Chromosome studies in the non-Hodgkin's lymphomas: The role of the 14;18 translocation. J Clin Oncol. 6:919–925. 1988. View Article : Google Scholar

Freedman A and Jacobsen E: Follicular lymphoma: 2020 Update on diagnosis and management. Am J Hematol. 95:316–327. 2020. View Article : Google Scholar

Maitre E, Wiber M, Cornet E and Troussard X: Hairy cell leukemia. Presse Med. 48:842–849. 2019. View Article : Google Scholar : PubMed/NCBI

Mathas S, Hartmann S and Küppers R: Hodgkin lymphoma: Pathology and biology. Semin Hematol. 53:139–147. 2016. View Article : Google Scholar

Wang HW, Balakrishna JP, Pittaluga S and Jaffe ES: Diagnosis of Hodgkin lymphoma in the modern era. Br J Haematol. 184:45–59. 2019. View Article : Google Scholar

Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD and Jaffe ES: The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 127:2375–2390. 2016. View Article : Google Scholar : PubMed/NCBI

Jain P and Wang M: Mantle cell lymphoma: 2019 Update on the diagnosis, pathogenesis, prognostication, and management. Am J Hematol. 94:710–725. 2019. View Article : Google Scholar

Klonou A, Korkolopoulou P, Gargalionis AN, Kanakoglou DS, Katifelis H, Gazouli M, Chlamydas S, Mitsios A, Kalamatianos T, Stranjalis G, et al: Histone mark profiling in pediatric astrocytomas reveals prognostic significance of H3K9 trimethylation and histone methyltransferase SUV39H1. Neurotherapeutics. 18:2073–2090. 2021. View Article : Google Scholar

Treisman J and Garlie N: Systemic therapy for cutaneous melanoma. Clin Plast Surg. 37:127–146. 2010. View Article : Google Scholar

Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Bastholt L, Bataille V, Del Marmol V, Dréno B, Fargnoli MC, et al: European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment-update 2019. Eur J Cancer. 126:159–177. 2020. View Article : Google Scholar

Nikolaou VA, Stratigos AJ, Flaherty KT and Tsao H: Melanoma: New insights and new therapies. J Invest Dermatol. 132:854–863. 2012. View Article : Google Scholar

Lugowska I, Teterycz P and Rutkowski P: Immunotherapy of melanoma. Contemp Oncol (Pozn). 22:61–67. 2018.

Karia PS, Han J and Schmults CD: Cutaneous squamous cell carcinoma: Estimated incidence of disease, nodal metastasis, and deaths from disease in the United States. 2012.J Am Acad Dermatol. 68:957–966. 2013. View Article : Google Scholar

Stratigos AJ, Garbe C, Dessinioti C, Lebbe C, Bataille V, Bastholt L, Dreno B, Fargnoli MC, Forsea AM, Frenard C, et al: European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. Epidemiology, diagnostics and prevention. Eur J Cancer. 128:60–82. 2020. View Article : Google Scholar : PubMed/NCBI

Parikh SA, Patel VA and Ratner D: Advances in the management of cutaneous squamous cell carcinoma. F1000Prime Rep. 6:702014. View Article : Google Scholar : PubMed/NCBI

Cranmer LD, Engelhardt C and Morgan SS: Treatment of unresectable and metastatic cutaneous squamous cell carcinoma. Oncologist. 15:1320–1328. 2010. View Article : Google Scholar

Soura E, Gagari E and Stratigos A: Advanced cutaneous squamous cell carcinoma: How is it defined and what new therapeutic approaches are available? Curr Opin Oncol. 31:461–468. 2019. View Article : Google Scholar